Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

126 Mothers * multifocal

12th World AIDS Conference

SKeyword

Abstract -

-Keyword

Abstract --

-1 subtype E in infected mothers and their infants/V3 sequence di 11184
en born to HIV-infected /Vertical transmission of hepatitis 12168
ion in infants of positive to HIV total breastfeeding impact 12175
en born to HIV-infected in Valencia (Spain)/Epidemiolog 13372
studies of Puerto Rican and adolescent daughters/Settin 235*/13404
uiting African-American and teens for HIV prevention inter 13420
1 but not HIV-2 positive fail to develop a BCG scar/HIV n 21210
nta of HIV-seropositive undergoing antiviral therapy/The 23286
IV transmission from to infants in Ontario 1994 to 1996: 23288
lasma in HIV infected /Determination of viral load in bre 23400
rs for young adolescent /Longitudinal study of HIV-related 23499
orn of HIV-seropositive /Emotional needs and behavioral 24147
North America for HIV+ and children/The new undergrou 24293
nts born to HIV-positive /Strong cytotoxic T cell response 31157
d non-infected lactating /Study of cellular and humoral im 31163
ence in children born to with HIV infection/Human herpes 31191
Counselling services for attending a mother-child researc 33308
efore death with single in the Slums of Nairobi/What will 48*/34187
nts born to HIV-infected,Thailand/RNA and DNA PCR for 166*/42106
s born from HIV infected /Total IgE levels in infants born fr 42112
W and single homeless in Maputo, Mozambique, 1997/M 43343
ments of children whose have died of AIDS/Child care arr 44212
abandon in HIV infected /Factors associated with child ab 44218
ve behaviour for single in Nairobi urban and peri-urban sl 60456
nts born to seropositive: A prospective study using 3 virol 60667
meroon/Mobilisation of leaving in rural area against STD/ 60989
tions of the information- motivation -behavioral skills model to HIV 43319
ct/Learning by doing: A for public health workers in a T 43532
ors in the hu-PBL-SCID mouse system/Control of HIV-1 proliferati 276*/21102
es in the hu-PBL-SCID model/Study of the impact of neutr 330*/31103
survey in Adjumani and Moyo Districts, northern Uganda/Why do 33120
rategies: Experience of Mozambique /WHO recommendations for 41166
bility of HIV rapid test in: Technical aspect/Feasibilit 41171
ch women with STDs in: Results of the KAP study, M 43251
ess mothers in Maputo,, 1997/Mobilisation to protec 43343
mbique/Legal reform in,an opportunity to introduce 44106
ogy of HIV-1 in Maputo, /Molecular epidemiology of 60722
xt of AIDS prevention in Mpigi District (Uganda)/Constraints to con 33110
yptococcal infections at Central Hospital, Bulawayo, Zimbab 60282
ements by whole body MRI and DXA scans/Altered body fat distri 32181
e molecular analysis of mRNA expression of HIV-infected T cell us 380*/11139
ative analysis of TNF-a by competitive RT-PCR in PBMC of 21181
ucosal genomic and /Different effects of disease progre 32112
of unspliced HIV-1 gag by the antisense oligonucleotides 41246
n of human chemokine mRNAs by reverse transcription/competiti 21177
Multidrugs resistant TB ( MRTB ): Study of an outbreak in HIV patient 615*/13274
n and also inject drugs ( MSM-IDU ) in Denver/The relationship bet 23406
n and also inject drugs ( ): A profile of the group at highest 23550
ence monitoring in IDU, MSM,STD patients, and pregnancies in SI 13189
ho have sex with men ( ) enrolled in a cohort study on HIV inci 14106
primary partners/HIV+ in discordant relationships report sex 14176
ve sex with other men ( ): A community study/Predisposing ri 14217
n having sex with men ( ) in Vancouver, Canada/Evidence of 23118
ho have sex with men ( )/Use of targeted outreach and Orasu 23138
ho have sex with men ( ): The Bela Vista Cohort Study, Sao P 23140
who have sex with men ( )/Unprotected oral sex among men w 23142
xual practices amongst in public sex environment in Dhaka of 23144
/Risky sexual amongst in public sex environment in Dhaka of 23148
ho have sex with men ( )/Risk factors for HIV seroconversion 23350
ho have sex with men ( ) in Sao Paulo, Brazil: The Bela Vista 23367
ho have sex with men ( ) belonging to support groups in the pr 23432
oject among RFSW and /AIDS surveillance and education pro 23558
who have sex with men ( ) in the Tokyo Metropolitan area/Pote 33109
who have sex with men ( ): Implication for prevention interventi 33180
ho have sex with men ( )/Potential public health impact of off 576*/33183
n having sex with men ( ) and injection drug users (IDUs)/Fea 33214
ho have sex with men ( ): Critical issues/Client-centered cou 33303
phetamine use among, men who have sex with other men: I 34158
mapping of sites where meet in Mumbai Metro/Sex mapping 43288
vention among Chinese in Hong Kong's "gay saunas"/HIV int 403*/43316
o have sex with males ( ) in Calcutta/Providing support servic 43332
d verbal harassment of 's in public sex environment/A study 44179
n having sex with men ( )/Sensitisation of health bureaucrats, 44237
o have sex with males ( ): Promoting supportive social enviro 60207

n having sex with men ( ) participating in two cohort studies in 60524
ave sex with other men ( ) in a conservative society/Reaching 60901
nd outreach amongst /Existing laws: Impediment to interve 60918
who have sex with men ( MSMs )/HIV sexual risk among subgroups 14158
ho have sex with men ( ) in major American cities/A method 24172
pie of HIV seropositive in major US cities/Prevalence of an 33169

ho have sex with males ( ) in Pakistan/HIV/AIDS among male
tisystem organ failure ( ) score for pneumocystis carinii pne
h for males selling sex ( MSS ) in Calcutta/Setting up street-based
ng campaigns against " MST "and AIDS?/Why is it important to ass
ing campaigns against and AIDS?/Why is it important to org
E/Coreceptor use and MT 2 tropism of HIV-1 chimeric clones havi
R-based assay and the 2 coculture method for the follow-up of s
acterium tuberculosis ( MTB ) in a general hospital, AIDS reference
ntervention program to MtF transgenders in Hollywood, CA/A com
reatment of 400 cases/ Mucocutaneous infections in Romanian
ospective cohort study/ problems in HIV-infected
V infection in Romania/ manifestations associat
d/First Cuban record of mucormycosis in a HIV infected child/Firs
d and CD4 T cells in the mucosa-associated lymphoid tissue (MA
duction in the intestinal mucosa in vivo/Evidence that beta-chemo

43280
22188
43331
34345
60088
11113
42192
22163
43305
32266
32270
32274
60863
41185
21120

hedding from anorectal /Antiretroviral therapy and HIV-1 23393
ant SHIV by systemic or mucosal inoculations/AIDS induction in rh 11244
mokine co-receptors on versus circulating CD4+ T cells in 21119
ard strong systemic and immunity/Improvement of nuclei 21205
ostitutes/HIV-1 specific IgA in a cohort of HIV-1 resistant 329*/31101
activity of seven human fluids/Evaluation of the HIV-inhib 31106
oviral therapy upon HIV genomic and mRNA/Different eff 32112
ntion: Evaluation of oral transudate-based HIV testing/N 43106
gency HIV Study/Oral lesions, CD4 count, viral load an 60299
embers by Syed Abdul Mujeeb and Shouket Ali/Human rights viol 44152
brile adults admitted to Mulago hospital in Kampala, Uganda/Co 22109
matic HIV-1 infection in hospital/Maternal morbidity follow 32229
-child research clinic at hospital/Counselling services for 33308
anisation clinic - TASO experience/Treating tuberculosis 60146
unity site/Awareness in Mulanda community site/Awareness in 23434
CSWs in Red Ligh area, Multan /Change of sex behaviour in CSWs 23570
roviding AIDS care to multi-diagnosed Aboriginal people in the 24267
n HIV/AIDS in Africa/A multi-disciplinary approach to demograp 24113
ffected by HIV/AIDS: A,decentralized, collabo 24209
RT) for HIV infection/A approach to maximize 32397
ntibodies in macaques/ Multi-epitope polypeptide TAB9 adjuvate 21216
I HIV-1 V3 recombinant multi-epitope polypeptide: TAB 9/Lymph 21215
ation with HIV-1 derived polypeptides (MEPs)/Selec 33224
or HIV positive men in a multi-ethnic urban sample in the US/Cult 14223
rkers who are HIV+ in a /religious environment/Holisti 32452
ching for consensus/A multi-institutional street-youth preventio 43234
of a scientifically sound multi-micronutrients intervention study in 44124
AIDS control in Uganda/ Multi-sectoral collaboration for HIV/AIDS 43540
truckers/Developing a multi-sectoral approach to STD/AIDS pre 13447
rol project (PPLS)/The Multi-sectorial approach through a struct 44254
CO in an expanded and multi-sectorial response to HIV/AIDS: Th 13518
ne responses to HIV-1/ Multi-subtype envelope-based DNA and 551*/21196
ion and quantitation by multi-target reverse transcription (RT)-lin 41139
azilian blood donors by reverse transcription (RT)-lin 42134
ting prior to AIDS in the Multicenter AIDS Cohort Study (MACS)/ 506*/32167
and whole blood spots/ evaluation of HIV-1 RNA level 33166
S-IP1 Study Group)/A multicenter randomised study comparing 132*/12237
patients (QUAVISC)/A cohort study on health-related 14352
266-006]/A phase II,, randomized, open-label stud 22336
d, placebo-controlled, study to determine the effectiv 22343
utcome. A prospective evaluation (German AIDS Stu 22368
a phase II, open-label, study at 24 weeks (Study DM 22386
xtension of an ongoing study/Very low HIV seroconv 23169
European prisoners: A study of the EC Network on HI 23527
prescription profile in a cohort of HIV+ pregnant wom 61001
) of HIV-1: International pooled analysis/Late post-nat 456*/23266
penic AIDS patients/A European, randomised, singl 32146
ation: The challenges of multicultulism /Integrating a sociolinguisti 24166
ng/"Bridging the gap" in multidisciplinary education and training/" 22434
teristics of patients in a group of AIDS at a Univ 24372
ting/The PEP Team: A team approach to provid 60200
gation of an outbreak of multidrug-resistant tuberculosis in a cent 13203
aintenance/NGC 891: Multidrug regime in HIV infection as an alt 60044
pie therapy/Alternative multidrug regimen provides improved sup 11156
ity/Combination of the resistance mutation Q151M/L a 32300
ance with antiretroviral therapy in HIV-infected patients 32371
nce the introduction of therapies at a local tertiary HIV r 42450
utbreak in HIV patients/ Multidrugs resistant TB (MRTB): Study of 615*/13274
tients with progressive multifocal leukoencephalopathy/Quantita 22266
lopment of progressive leukoencephalopathy/Analysis 22322
h cidofovir/Progressive leukoencephalopathy (PML) tre 562*/32193
inhibitors/Progressive leucoencephalopathy in AIDS: 32194
urrence of progressive leukoencephalopathy (PML) in 32199
nd without progressive leukoencephalopathy (PML)/D 32210
ssociated progressive leukoencephalopaty with anti-r 32221